{"id":"W4283516981","doi":"10.1016/j.msard.2022.103995","title":"Use of natalizumab in persons with multiple sclerosis: 2022 update","year":2022,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; Université de Sherbrooke; University of British Columbia; Memorial University of Newfoundland; Western University","funders":"","keywords":"Natalizumab; Medicine; Multiple sclerosis; Progressive multifocal leukoencephalopathy; Dosing; Adverse effect; Intensive care medicine; Internal medicine; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002441602,0.0008732226,0.00249415,0.0009049656,0.000325018,0.00005784578,0.0002647083,0.0007559002,0.0006964574],"category_scores_gemma":[0.0002779072,0.000633389,0.0008255314,0.001545236,0.0004926266,0.000234592,0.0002750145,0.001493567,0.00001882462],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001999002,"about_ca_system_score_gemma":0.0004165338,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00148664,"about_ca_topic_score_gemma":0.0003622315,"domain_scores_codex":[0.9959857,0.000324252,0.001254488,0.001078681,0.0006309732,0.0007258953],"domain_scores_gemma":[0.9975998,0.0005154502,0.0006792936,0.0007643105,0.00004311396,0.0003979797],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0008167009,0.001784398,0.005196963,0.007477839,0.002147076,0.00008781832,0.0005075173,0.0001178198,0.00002103995,0.00003237495,0.001089031,0.9807214],"study_design_scores_gemma":[0.009454138,0.0007143983,0.004615321,0.03082879,0.004676375,0.0001012232,0.0007598922,0.0009432558,0.000004014163,0.000007834959,0.9466426,0.001252208],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.009731608,0.9865528,0.000002137774,0.0000903507,0.0002546575,0.002020706,0.0009839509,0.0001210574,0.0002427411],"genre_scores_gemma":[0.01977831,0.9778824,0.0001200781,0.00005728609,0.00001856715,0.0003702914,0.001155978,0.0002070382,0.0004100251],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9794692,"threshold_uncertainty_score":0.9996117,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07109589134726166,"score_gpt":0.2656694784780308,"score_spread":0.1945735871307691,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}